Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Evaluate the dose-response relationship with respect to the efficacy of symptomatic treatment and safety of three doses of ABT-126 in subjects with mild to moderate AD. The primary efficacy measure is the Alzheimer's Disease Assessment Scale – cognitive subscale (ADAS-Cog).
Critère d'inclusion
- Alzheimer's disease